Latest News | Zydus MedTech Ties Up with Brazil's Braile Biomedica

New Delhi, Apr 17 (PTI) Zydus MedTech on Thursday said it has entered into a pact with Braile Biomedica, an innovative cardiovascular device manufacturer based in Brazil.

As part of the collaboration, Zydus will exclusively commercialise Braile's Transcatheter Aortic Valve Implantation technology (TAVI) across Europe, India, and other select markets.

Also Read | How Many Dolo 650 Can Be Taken in a Day? As US Doctor's 'Indians Take Dolo 650 Like It's Cadbury Gems' Post Goes Viral, Know How Much Paracetamol Is Safe for Your Body.

The global TAVI market, currently valued at over USD 6 billion, continues to witness strong growth driven by the increasing incidence of aortic stenosis and the rising demand for minimally invasive cardiac procedures.

"We stand united with Braile to improve patient outcomes and expand access to advanced, critical cardiovascular care globally," Zydus Lifesciences MD Sharvil Patel said in a statement.

Also Read | Bodoland Lottery Result Today, April 17, 2025: Assam State Lottery Sambad Thursday Lucky Draw Results Declared, Check Winners List With Ticket Numbers.

This technology will offer a minimally invasive approach that also supports faster recovery, reduced hospital stays, and greatly improved quality of life for patients, he added.

Zydus MedTech is a wholly-owned subsidiary of Zydus Lifesciences specialising in medical technology development.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)